Skip to main content

C-RAD publishes annual report for 2022

C-RADs Annual Report for 2022 is now available online at the company website. The Annual Report can be downloaded in pdf version. Please visit www.c-rad.com/investors/financial-reports/

For further information:

Cecilia de Leeuw, CEO, +46 (0)18 751 33 22, investors@c-rad.com

About C-RAD

C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.

C-RAD. Inspiring excellence in cancer treatment.

C-RAD AB is listed on NASDAQ Stockholm.

For more information on C-RAD, please visit https://www.c-rad.com

This information is information that C-Rad is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 2023-04-06 10:30 CEST.

Attachments

C-RAD Annual Report Eng 2022

C-RAD Annual Report Eng 2022
Close Menu